scanX
Home
GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals

2,698.35
-100.55
(-3.59%)
Market Cap (₹ Cr.)
₹47,434
52 Week High
3,088.00
Book Value
₹105
52 Week Low
1,385.05
PE Ratio
61.58
PB Ratio
26.68
PE for Sector
50.94
PB for Sector
90.92
ROE
33.19 %
ROCE
107.89 %
Dividend Yield
1.14 %
EPS
₹45.47
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Multinational
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
6.68 %
Net Income Growth
-2.91 %
Cash Flow Change
20.19 %
ROE
-4.90 %
ROCE
7.13 %
EBITDA Margin (Avg.)
6.83 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
659
692
749
777
746
731
817
739
801
609
851
716
767
753
831
870
824
819
1,299
795
802
706
888
835
778
747
946
831
2,114
760
928
823
821
792
982
833
943
847
Expenses
498
543
597
646
577
615
658
654
623
563
644
562
594
604
663
688
611
623
688
1,391
602
534
739
611
702
570
662
629
619
582
649
583
615
597
667
751
656
582
EBITDA
160
149
152
131
169
116
159
85
178
46
207
154
173
150
168
182
213
196
611
-596
201
172
150
224
76
177
284
201
1,496
179
279
240
205
195
315
83
288
265
Operating Profit %
19 %
14 %
15 %
12 %
18 %
10 %
18 %
7 %
18 %
3 %
23 %
20 %
21 %
18 %
19 %
17 %
19 %
21 %
22 %
-79 %
22 %
18 %
16 %
23 %
5 %
19 %
28 %
22 %
22 %
20 %
28 %
27 %
21 %
19 %
30 %
7 %
28 %
28 %
Depreciation
5
5
5
8
7
5
7
7
8
8
8
13
9
11
12
12
14
19
23
18
23
22
22
18
18
18
17
18
15
16
16
16
17
16
18
17
18
16
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
3
2
1
1
1
1
1
0
1
0
1
0
0
1
0
0
0
1
0
Profit Before Tax
156
144
146
123
163
111
152
78
170
38
199
140
164
138
156
170
199
176
587
-617
176
149
127
205
58
159
266
183
1,480
162
262
224
187
179
297
65
269
248
Tax
53
50
51
45
62
38
55
26
44
12
68
53
72
45
51
69
28
56
65
81
58
38
48
54
34
42
67
39
260
47
73
69
57
53
91
31
61
63
Net Profit
103
94
96
79
106
72
99
53
113
26
130
90
106
89
101
113
123
113
503
-644
138
111
77
157
13
120
203
150
1,218
119
194
164
131
131
216
45
193
182
EPS in ₹
12.10
11.00
11.30
9.30
12.50
8.50
11.70
6.30
13.31
3.12
15.40
10.59
6.23
10.46
5.95
6.67
7.26
6.70
29.68
-38.02
8.14
6.55
4.52
9.29
0.75
7.10
11.96
8.83
71.89
7.01
11.42
9.68
7.28
6.94
12.72
2.69
11.29
10.72
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
3,236
3,071
3,021
3,965
3,909
3,132
3,097
4,623
3,328
3,548
Fixed Assets
123
210
258
325
432
758
387
331
330
321
Current Assets
2,565
2,148
1,650
2,163
1,991
1,757
2,171
3,671
2,467
2,766
Capital Work in Progress
115
268
605
923
1,003
120
13
31
20
14
Investments
0
48
48
48
25
24
24
390
543
838
Other Assets
2,998
2,545
2,110
2,670
2,450
2,229
2,672
3,871
2,435
2,375
Total Liabilities
1,385
866
993
1,885
1,767
1,291
1,600
1,945
1,575
1,764
Current Liabilities
1,106
575
717
1,596
1,451
1,002
1,319
1,674
1,317
1,511
Non Current Liabilities
279
291
275
289
316
289
281
271
258
253
Total Equity
1,852
2,205
2,028
2,080
2,142
1,840
1,497
2,678
1,753
1,784
Reserve & Surplus
1,767
2,120
1,944
1,995
1,973
1,671
1,328
2,508
1,584
1,615
Share Capital
85
85
85
85
169
169
169
169
169
169
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
22
-1
25
61
-102
0
307
-124
-251
32
Investing Activities
178
499
303
-107
-154
-63
408
-420
805
15
Operating Activities
348
138
232
475
411
491
595
820
488
579
Financing Activities
-497
-638
-511
-307
-358
-428
-696
-524
-1,544
-562
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
FIIs
1.59 %
1.61 %
1.72 %
2.04 %
2.18 %
2.16 %
2.17 %
2.29 %
2.28 %
2.41 %
2.50 %
2.92 %
3.48 %
4.02 %
DIIs
10.85 %
10.93 %
10.82 %
10.73 %
10.74 %
10.65 %
10.54 %
10.28 %
10.30 %
10.25 %
10.01 %
8.64 %
7.90 %
7.50 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
Public / Retail
12.56 %
12.46 %
12.45 %
12.23 %
12.09 %
12.19 %
12.29 %
12.43 %
12.43 %
12.34 %
12.48 %
13.43 %
13.62 %
13.48 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Abbott
27,971.60 61,353.43 49.52 6,097.18 10.80 1,201 13.01 37.10
GlaxoSmithKline Pharmaceuticals
2,698.35 47,433.69 61.58 3,576.30 6.68 590 37.87 39.33
Pfizer
5,667.30 27,100.04 44.97 2,373.68 -6.02 551 61.14 36.46
AstraZeneca Pharma
6,716.25 16,674.13 127.28 1,330.33 29.27 162 -121.89 47.38
Sanofi
7,177.55 16,544.18 33.68 2,916.40 - 603 -16.03 58.99
Sanofi Consumer Healthcare
5,349.95 11,871.48 - 0.00 - 0 -69.11 -
Procter & Gamble Health
5,101.20 8,505.01 39.52 1,248.01 10.68 229 -43.73 41.12

Corporate Action

Technical Indicators

RSI(14)
Neutral
39.33
ATR(14)
Volatile
89.54
STOCH(9,6)
Neutral
45.99
STOCH RSI(14)
Oversold
10.97
MACD(12,26)
Bearish
-16.94
ADX(14)
Weak Trend
24.88
UO(9)
Bearish
40.98
ROC(12)
Downtrend And Accelerating
-4.72
WillR(14)
Oversold
-91.04
Bearish
3
Neutral
5
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.